HomeTagsAmgen's Neulasta drug

All Stories: Amgen's Neulasta drug

FDA knocks back Novartis copy of Amgen’s drug Neulasta

WASHINGTON: U.S. regulators have declined to approve Novartis' so-called biosimilar copy of Amgen's Neulasta drug that fights infections in cancer patients, the Swiss drugmaker said on Tuesday.

-Advertisement-

PM expresses grief over martyrdom of innocent citizens in Tirah Valley

MUST READ

InternationalReuters - July 28, 2025

Thai and Cambodian leaders head to Malaysia for peace talks

InternationalAgencies - July 28, 2025

Israeli strikes kill 63 in Gaza despite ‘pauses’, as hunger crisis deepens

Must ReadWeb Desk - July 28, 2025

Missing tourist family identified after being swept away at Babusar Top

Must ReadWeb Desk - July 27, 2025

Audit reveals 80 government vehicles missing in KP

BusinessWeb Desk - July 27, 2025

Ahsan Iqbal highlights Gwadar’s mineral potential in meeting with Chinese Ambassador

Must ReadWeb Desk - July 27, 2025

All Stories: Amgen's Neulasta drug

FDA knocks back Novartis copy of Amgen’s drug Neulasta

Trending

BREAKING NEWS

Terrorists behind attack on Chinese nationals killed in Karachi

European Union resigned to 15 percent US tariff

PM expresses grief over martyrdom of innocent citizens in Tirah Valley

MUST READ

Thai and Cambodian leaders head to Malaysia for peace talks

Israeli strikes kill 63 in Gaza despite ‘pauses’, as hunger crisis deepens

Missing tourist family identified after being swept away at Babusar Top

Audit reveals 80 government vehicles missing in KP

Ahsan Iqbal highlights Gwadar’s mineral potential in meeting with Chinese Ambassador

Pakistan to launch satellite for geospatial mapping of key CPEC projects

ABOUT US

CORPORATE

ARY NETWORK

DOWNLOAD NOW!